OTC Acetaminophen Access Limitations To Be Considered By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA is considering examining more extensive ways to inform consumers about the dangers of acetaminophen as well as techniques to limit access to OTC drugs containing the analgesic ingredient.
You may also be interested in...
Barriers To Making Acetaminophen Changes Form Basis For Opposition
Implementing an FDA working group's recommendations to reduce acetaminophen-induced liver injury poses significant challenges that the drug industry could cite in arguing against potential restrictions
Barriers To Making Acetaminophen Changes Form Basis For Opposition
Implementing an FDA working group's recommendations to reduce acetaminophen-induced liver injury poses significant challenges that the drug industry could cite in arguing against potential restrictions
Barriers To Making Acetaminophen Changes Form Basis For Opposition
Implementing an FDA working group's recommendations to reduce acetaminophen-induced liver injury poses significant challenges that the drug industry could cite in arguing against potential restrictions